Primary ciliary dyskinesia: Meeting the challenges of diagnosis in South Africa
DOI:
https://doi.org/10.7196/SAMJ.2024.v114i8.2069Keywords:
primary ciliary dyskinesia, PCD, diagnosisAbstract
Primary ciliary dyskinesia (PCD) is an inherited ciliopathy that results in impaired mucous clearance and affects primarily the respiratory tract, causing upper airway disease, bronchial inflammation and bronchiectasis. The prevalence of PCD in low- and middle-income settings, including South Africa (SA), is unknown, largely owing to challenges with diagnosis, and identifying children or adults with PCD is challenging in a setting with a high prevalence of other infectious diseases, including lower respiratory tract infections and tuberculosis. No single test is diagnostic of PCD, and while some tests are costly, others are labour intensive and require highly specialised laboratory expertise. In the SA setting, awareness and opportunities for the diagnosis of PCD need to be created. In this commentary, we provide a pragmatic approach to identifying which children and adults require further investigations for PCD using a range of diagnostic tests or tools that are available. Furthermore, we recommend that designated centres of expertise for PCD diagnosis are created in SA. This would be an important step towards improving accessibility of diagnostic tests and developing local expertise to improving PCD diagnosis, especially in early childhood, to prevent long-term irreversible respiratory sequelae.
References
Verwey C, Gray DM, Dangor Z, et al. Bronchiectasis in African children: Challenges and barriers to care. Front Pediatr
;10:954608. https://doi.org10.3389/fped.2022.954608
Goutaki M, Shoemark A. Diagnosis of primary ciliary dyskinesia. Clin Chest Med 2022;43(1):127-140. https://doi.org10.1016/j.
ccm.2021.11.008
Legendre M, Zaragosi LE, Mitchison HM. Motile cilia and airway disease. Semin Cell Dev Biol 2021;110:19-33. https://doi.
org10.1016/j.semcdb.2020.11.007
Ghanaeian A, Majhi S, McCafferty CL, et al. Integrated modeling of the Nexin-dynein regulatory complex reveals its regulatory
mechanism. Nat Commun 2023;14(1):5741. https://doi.org10.1038/s41467-023-41480-7
Fassad MR, Patel MP, Shoemark A, et al. Clinical utility of NGS diagnosis and disease stratification in a multiethnic primary ciliary
dyskinesia cohort. J Med Genet 2020;57(5):322-330. https://doi.org10.1136/jmedgenet-2019-106501
Lucas JS, Davis SD, Omran H, Shoemark A. Primary ciliary dyskinesia in the genomics age. Lancet Respir Med 2020;8(2):202-
https://doi.org10.1016/S2213-2600(19)30374-1
Kim DY, Sub YJ, Kim HY, et al. LRRC6 regulates biogenesis of motile cilia by aiding FOXJ1 translocation into the nucleus. Cell
Commun Signal 2023;21(1):142. https://doi.org10.1186/s12964-023-01135-y
Hannah WB, Seifert BA, Truty R, et al. The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: A
genetic database analysis. Lancet Respir Med 2022;10(5):459-468. https://doi.org10.1016/S2213-2600(21)00453-7
Rumman N, Fassad MR, Driessens C, et al. The Palestinian primary ciliary dyskinesia population: First results of the
diagnostic and genetic spectrum. ERJ Open Res 2023;9(2):00714-2022. https://doi.org10.1183/23120541.00714-2022
Pedersen ESL, Goutaki M, Schreck LD, Lucas JS, Kuehni CE, Eastvold T. Genotype-phenotype associations in primary
ciliary dyskinesia. ERS International Congress: Euro Respir J 2023(62):PA2763. https://doi.org10.1183/13993003.
congress-2023.PA2763
Surdut SP, van der Merwe E, Goussard P, Urban MF. Which side are they on? Diagnosing primary ciliary dyskinesias in
low- or middle-income countries: A review and case series. Afr J Thorac Crit Care Med 2023;29(3):e425. https://doi.org/10.7196/
AJTCCM.2023.v29i3.425
O’Connor MG, Horani A, Shapiro AJ. Progress in diagnosing primary ciliary dyskinesia: The North American perspective.
Diagnostics (Basel) 2021;11(7):1278. https://doi.org10.3390/diagnostics11071278
Nussbaumer M, Kieninger E, Tschanz SA, et al. Diagnosis of primary ciliary dyskinesia: Discrepancy according to different
algorithms. ERJ Open Res 2021;7(4):00353-2021. https://doi.org10.1183/23120541.00353-2021
Shapiro AJ, Davis SD, Polineni D, et al. Diagnosis of primary ciliary dyskinesia. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med 2018;197(12):e24-e39. https://doi.org10.1164/rccm.201805-0819ST
Shoemark A, Dell S, Shapiro A, Lucas JS. ERS and ATS diagnostic guidelines for primary ciliary dyskinesia: Similarities and
differences in approach to diagnosis. Eur Respir J 2019;54(3):190-1066. https://doi.org10.1183/13993003.01066-2019
Shapiro AJ, Dell SD, Gaston B, et al. Nasal nitric oxide measurement in primary ciliary dyskinesia. A technical paper on
standardised testing protocols. Ann Am Thorac Soc 2020;17(2):e1-e12. https://doi.org10.1513/AnnalsATS.201904-347OT
Beydon N, Kouis P, Marthin JK, et al. Nasal nitric oxide measurement in children for the diagnosis of primary
ciliary dyskinesia: European Respiratory Society technical standard. Eur Respir J 2023;61(4):2202031. https://doi.org/10.1183/13993003.02031-2022
Raidt J, Krenz H, Tebbe J, et al. Limitations of nasal nitric oxide measurement for diagnosis of primary ciliary dyskinesia with
normal ultrastructure. Ann Am Thorac Soc 2022;19(8):1275-1284. https://doi.org10.1513/AnnalsATS.202106-728OC
Horani A, Brody SL. One person can make a difference: Identification of people with a rare genetic lung disease.
ERJ Open Res 2023;9(2):00122-2023. https://doi.org10.1183/23120541.00122-2023
Raidt J, Wallmeier J, Hjeij R, et al. Ciliary beat pattern and frequency
in genetic variants of primary ciliary dyskinesia. Eur Respir J 2014;44(6):1579-1588. https://doi.org10.1183/09031936.00052014
Shoemark A, Boon M, Brochhausen C, et al. International consensus guideline for reporting transmission electron
microscopy results in the diagnosis of primary ciliary dyskinesia (BEAT PCD TEM Criteria). Eur Respir J 2020;55(4):1900725.
https://doi.org10.1183/13993003.00725-2019
Castillo M, Freire E, Romero VI. Primary ciliary dyskinesia diagnosis and management and its implications in America:
A mini review. Front Pediatr 2023;11:1091173. https://doi.org10.3389/fped.2023.1091173
Austero RM, Gelera JE. Evaluation of nasal mucociliary clearance using saccharin test versus charcoal test among Filipinos in a
tertiary government hospital. Cureus 2022;14(2):e22065. https://
doi.org10.7759/cureus.22065
Rademacher J, Buck A, Schwerk N, et al. Nasal nitric oxide measurement and a modified PICADAR score for
the screening of primary ciliary dyskinesia in adults with bronchiectasis. Pneumologie 2017;71(8):543-548. https://doi.
org10.1055/s-0043-111909
Behan L, Dimitrov BD, Kuehni CE, et al. PICADAR: A diagnostic predictive tool for primary ciliary dyskinesia. Eur Respir J
;47(4):1103-1112. https://doi.org10.1183/13993003.01551-2015
De Jesús-Rojas W, Reyes-Peña L, Muñiz-Hernández J, et al. Bronchiectasis assessment in primary ciliary dyskinesia: A
non-invasive approach using forced oscillation technique. Diagnostics (Basel) 2023;13(13):2287. https://doi.org10.3390/
diagnostics13132287
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Z Dangor, M Birkhead, C Verwey, D Gray, A Vanker, L Githinji, A Goga, R Masekela, M Zampoli
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
